Targeting type 2 immune activation beyond atopic dermatitis.

Leung, Donald Y M; Facheris, Paola; Veverka, Karen A; Cevikbas, Ferda; Guttman-Yassky, Emma

Leung, Donald Y M; Facheris, Paola; Veverka, Karen A; Cevikbas, Ferda; Guttman-Yassky, Emma.

Afiliación

Leung DYM; Pediatric Allergy and Clinical Immunology, Department of Pediatrics, National Jewish Health, Denver, Colorado. Electronic address: leungd@njhealth.org.
Facheris P; Department of Dermatology, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Humanitas Rozzano, Milan, Italy.
Veverka KA; ASLAN Pharmaceuticals, San Mateo, California.
Cevikbas F; ASLAN Pharmaceuticals, San Mateo, California.
Guttman-Yassky E; Dermatology and Clinical Immunology, Icahn School of Medicine at Mount Sinai, New York, New York.

Ann Allergy Asthma Immunol ; 132(2): 121-123, 2024 Feb.

Article en En | MEDLINE | ID: mdl-37442541

Asunto(s)

Dermatitis Atópica; Humanos; Piel; Citocinas

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Dermatitis Atópica Límite: Humans Idioma: En Revista: Ann Allergy Asthma Immunol Asunto de la revista: ALERGIA E IMUNOLOGIA Año: 2024 Tipo del documento: Article

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google